Cleared Traditional

K011690 - MAMMOSITE RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER ACCESSORIES TRAY

K011690 is an FDA 510(k) clearance for MAMMOSITE RADIATION THERAPY SYSTEM (RTS..., manufactured by Proxima Therapeutics, Inc.. The device is a Class 2 Radiology device with product code JAQ cleared through the Traditional 510(k) pathway after a 340-day FDA review.

K011690 · Proxima Therapeutics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2002
Decision
340d
Days
Class 2
Risk

K011690 is an FDA 510(k) clearance for the MAMMOSITE RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER ACCE.... Classified as System, Applicator, Radionuclide, Remote-controlled (product code JAQ), Class II - Special Controls.

Submitted by Proxima Therapeutics, Inc. (Alpharetta, US). The FDA issued a Cleared decision on May 6, 2002 after a review of 340 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5700 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Proxima Therapeutics, Inc. devices

FDA 510(k) Submission Details - K011690

510(k) Number K011690 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received May 31, 2001
Decision Date May 06, 2002
Days to Decision 340 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
233d slower than avg
Panel avg: 107d · This submission: 340d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAQ Device Classification - Class 2, Special Controls

Product Code JAQ System, Applicator, Radionuclide, Remote-controlled
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAQ System, Applicator, Radionuclide, Remote-controlled

All 143
Devices cleared under the same product code (JAQ) and FDA review panel - the closest regulatory comparables to K011690.
VARISOURCE BREAST TEMPLATE SYSTEM
K023220 · Varian Medical Systems · Oct 2002
KUSKE BREAST APPLICATOR SET, MODEL 189.006
K022635 · Nucletron Corporation · Sep 2002
MICROSELECTRON HDR- GENIE AFTERLOADING SYSTEM, MODEL 105.989 FOR 115VOLT DEVICES AND 105.988 FOR 230VOLT DEVICES
K021286 · Nucletron Corp. · May 2002
HDR MIAMI APPLICATOR
K020176 · Mick Radio-Nuclear Instruments, Inc. · Apr 2002
IMPLANT GUIDANCE SYSTEM APPLICATOR SET
K020015 · Nucletron Corp. · Mar 2002
SEED SELECTRON MODEL V. 1.0
K010032 · Nucletron Corp. · Oct 2001